Amino acid-based cationic lipid
AssigneeXiamen Sinopeg Biotech Co., Ltd.
InventorsSheng LIN, Wengui WENG, Chao LIU, Ailan WANG, Linlin WANG, Minggui LIN, Qi ZHU, Guohua WEI
Life of this patent
Estimating the term…
Loading patent…
AssigneeXiamen Sinopeg Biotech Co., Ltd.
InventorsSheng LIN, Wengui WENG, Chao LIU, Ailan WANG, Linlin WANG, Minggui LIN, Qi ZHU, Guohua WEI
Estimating the term…
The present invention introduces a novel amino acid-based cationic lipid, represented by the general formula (1), with symbols as defined herein. This lipid is pharmaceutically acceptable, biodegradable, or highly biocompatible, and offers low toxicity, low immunogenicity, and high compatibility. The amino acid or its derivatives used as starting materials are easily accessible, either naturally or through simple synthesis, making the process straightforward, safe, and cost-effective. The lipid structure may include degradable groups between the amino acid residue and lipophilic tail chains. The presence of degradable groups allows lipid nanoparticles (LNPs) to degrade within endosomes, addressing issues of LNP accumulation and endosomal acidification caused by non-degradable lipids in prior art. This facilitates the effective endosomal escape of drug molecules, such as nucleic acids, ensuring their proper cellular function after delivery.
An amino acid-based cationic lipid, wherein the structure is represented by the general formula (1):
24-26. (canceled)
Dependencies are inferred from the claim text.